13D Filings
Dianthus Therapeutics, Inc.
DNTH
Amendment
Ownership

4.90%

Total Shares

2,104,184

Issuer CIK

1690585

CUSIP

252828108

Event Date

Nov 16, 2025

Accepted

Nov 19, 2025, 09:15 PM

Reporting Persons (6)
Joint Filing

This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.

NameType% of ClassAggregateSole VotingShared Voting
Avidity Partners Management LP
Investment Adviser
4.90%2,104,18402,104,184
Avidity Partners Management (GP) LLC
Holding Company
4.90%2,104,18402,104,184
Avidity Capital Partners Fund (GP) LP
Partnership
4.90%2,104,18402,104,184
Avidity Capital Partners (GP) LLC
Other
4.90%2,104,18402,104,184
Michael Gregory
Individual
4.90%2,104,18402,104,184
Avidity Private Master Fund I LP
Partnership
4.40%1,899,59301,899,593
Disclosure Items (7)

Security Title

Common Stock, $0.001 par value

Issuer Name

Dianthus Therapeutics, Inc.

Issuer Address

7 TIMES SQUARE, NEW YORK, NY, 10036

Filing Persons

This statement is filed on behalf of each of the following person (collectively, the "Reporting Persons"): i. Avidity Partners Management LP; ii. Avidity Partners Management (GP) LLC; iii. Avidity Capital Partners Fund (GP) LP; iv. Avidity Capital Partners (GP) LLC; v. Avidity Private Master Fund I LP; and vi. Michael Gregory. The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons." Any disclosures herein with respect to a Reporting Persons is made by such Reporting Persons. The filing of this statement should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the securities reported herein. The Reporting Persons have entered into a joint filing agreement, filed as Exhibit A to this Amendment No. 3 to Schedule 13D, pursuant to which the Reporting Persons agreed to file the Schedule 13D and any amendments thereto in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.

Business Address

The address of the principal business office of each of the Reporting Persons is 2828 N Harwood Street, Suite 1220, Dallas, Texas 75201.

Principal Occupation

The principal business of Avidity Partners Management LP is managing investments. Avidity Partners Management (GP) LLC is the general partner of Avidity Partners Management LP. Avidity Capital Partners Fund (GP) LP serves as the general partner of private investment funds managed by Avidity Partners Management LP, including Avidity Private Master Fund I LP. Avidity Capital Partners (GP) LLC is the general partner of Avidity Capital Partners Fund (GP) LP. Mr. Gregory is the managing member of Avidity Partners Management (GP) LLC and Avidity Capital Partners (GP) LLC.

Convictions

None of the Reporting Persons have been a party to any civil proceeding of a judicial or administrative body of competent jurisdiction resulting in any judgment, decree or final order enjoining them from engaging in future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws during the last five years.

Citizenship

i. Avidity Partners Management LP is a Delaware limited partnership; ii. Avidity Partners Management (GP) LLC is a Delaware limited liability company; iii. Avidity Capital Partners Fund (GP) LP is a Delaware limited partnership; iv. Avidity Capital Partners (GP) LLC is a Delaware limited liability company; v. Avidity Private Master Fund I LP is a Cayman Islands exempted limited partnership; and vi. Michael Gregory is a citizen of the United States of America.

The funds used for the acquisition of the Issuer's Common Stock, $0.001 par value (the "Common Stock") beneficially owned by the Reporting Person came from the working capital of private funds advised by Avidity Partners Management LP. No borrowed funds were used to purchase the Common Stock other than any borrowed funds used for working capital purposes in the ordinary course of business.

The Reporting Persons are filing this Amendment No. 3 to report a greater than 1.00% decrease in the percentage of shares of Common Stock beneficially owned by the Reporting Persons due to the sale of shares of Common Stock by private investment funds managed by Avidity Partners Management LP, including Avidity Private Master Fund I LP. Although the Reporting Persons do not have any specific plan or proposal to acquire, transfer or dispose of Common Stock at the time of this filing, consistent with their investment purpose, the Reporting Persons may, either directly or through one or more affiliates, from time to time or at any time and subject to price, market and general economic and fiscal conditions and other factors, acquire or seek to acquire additional shares of Common Stock in the open market, in privately negotiated transactions or otherwise, or dispose of or seek to dispose of all or a portion of such shares of Common Stock now owned or hereafter acquired. The Reporting Persons reserve the right to change their intention with respect to any or all of the matters required to be disclosed in this Item 4. The Reporting Persons have not made a determination regarding a maximum or minimum number of shares of Common Stock or other securities of the Issuer that it may hold at any point in time. Except as set forth herein and below, or as would occur upon completion of any of the matters discussed herein, the Reporting Persons have no present plans or proposals that would relate to or result in any of the matters set forth in clauses (a) through (j) of Item 4 of Schedule 13D. Although the foregoing reflects activities presently contemplated by such persons with respect to the Issuer, the foregoing is subject to change at any time.

Percentage of Class

The information set forth in Items 2, 3 and 4 is hereby incorporated by reference into this Item 5. The aggregate number of shares of Common Stock and the percentage of total outstanding shares of Common Stock beneficially owned by the Reporting Persons is set forth below. References to percentage ownerships of shares of Common Stock in this statement are based on 42,876,015 shares of Common Stock outstanding as of November 3, 2025 as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 5, 2025. The filing of this statement shall not be construed as an admission that a Reporting Person beneficially owns those shares held by any other Reporting Person.

Number of Shares

Avidity Partners Management LP, Avidity Partners Management (GP) LLC, Avidity Capital Partners Fund (GP) LP, Avidity Capital Partners (GP) LLC and Michael Gregory have shared power to vote or to direct the vote and shared power to dispose or to direct the disposition of 2,104,184 shares of the Common Stock reported in (a) above.

Transactions

Avidity Private Master Fund I LP has shared power to vote or to direct the vote and shared power to dispose or to direct the disposition of 1,899,593 shares of the Common Stock reported in (a) above. The transactions in the Common Stock by the Reporting Persons during the past sixty days in respect of the Issuer are set forth on Exhibit B. All of the securities in this Schedule 13D are owned by advisory clients of Avidity Partners Management LP. Other than Avidity Private Master Fund I LP, no such client(s) is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock in an amount equal to more than five percent of the class. The Reporting Persons no longer beneficially own 5% or more of the total outstanding shares of Common Stock. Consequently, this Amendment No. 3 is the final amendment to the Schedule 13D and constitutes an "exit filing" for the Reporting Persons.

The information set forth in Items 2, 3, 4 and 5 is hereby incorporated by reference into this Item 6. The Reporting Persons do not have any contract, arrangement, understanding or relationship with any person with respect to securities of the Issuer that is not described herein and/or in a previous Schedule 13D filed by the Reporting Persons in respect of the Issuer.

A - Joint Filing Agreement B - Schedule of Transactions in the Common Stock

Dianthus Therapeutics, Inc. — Schedule 13D | 13D Filings